Validating the assumptions of population adjustment: application of multilevel network meta-regression to a network of treatments for plaque psoriasis

David M Phillippo*, Sofia Dias, A E Ades, Mark Belger, Alan Brnabic, Daniel Saure, Yves Schymura, Nicky J Welton

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

6 Citations (Scopus)
419 Downloads (Pure)

Abstract

Background: Network meta-analysis (NMA) and indirect comparisons combine aggregate data (AgD) from multiple studies on treatments of interest, but may give biased estimates if study populations differ. Population adjustment methods such as multilevel network meta-regression (ML-NMR) aim to reduce bias by adjusting for differences in study populations using individual patient data (IPD) from one or more studies under the conditional constancy assumption. A shared effect modifier assumption may also be necessary for identifiability. This paper aims to demonstrate how the assumptions made by ML-NMR can be assessed in practice to obtain reliable treatment effect estimates in a target population.

Methods: We apply ML-NMR to a network of evidence on treatments for plaque psoriasis with a mix of IPD AgD trials reporting ordered categorical outcomes. Relative treatment effects are estimated for each trial population and for three external target populations represented by a registry and two cohort studies. We examine residual heterogeneity and inconsistency, and relax the shared effect modifier assumption for each covariate in turn.

Results: Estimated population-average treatment effects were similar across study populations, as differences in the distributions of effect modifiers were small. Better fit was achieved with ML-NMR than NMA, and uncertainty was reduced by explaining within- and between-study variation. We found little evidence that the conditional constancy or shared effect modifier assumptions were invalid.

Conclusions: ML-NMR extends the NMA framework and addresses issues with previous population adjustment approaches. It coherently synthesises evidence from IPD and AgD studies in networks of any size whilst avoiding aggregation bias and non-collapsibility bias, allows for key assumptions to be assessed or relaxed, and can produce estimates relevant to a target population for decision-making.
Original languageEnglish
Pages (from-to)53-67
Number of pages15
JournalMedical Decision Making
Volume43
Issue number1
Early online date23 Aug 2022
DOIs
Publication statusPublished - 1 Jan 2023

Bibliographical note

Funding Information:
The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: DMP reports personal fees from UCB, Bristol Myers Squibb, and AstraZeneca outside of this work. SD, AEA, and NJW have no conflicts of interest to declare. MB, AB, DS, and YS are employees and shareholders of Eli Lilly and Company. The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the UK Medical Research Council, grant Nos. MR/P015298/1, MR/R025223/1, and MR/W016648/1

Publisher Copyright:
© The Author(s) 2022.

Research Groups and Themes

  • Multi-parameter Evidence Synthesis Research

Fingerprint

Dive into the research topics of 'Validating the assumptions of population adjustment: application of multilevel network meta-regression to a network of treatments for plaque psoriasis'. Together they form a unique fingerprint.
  • Methods Explained: Multilevel network meta-regression

    Degeling, K. (Editor), Jansen, J. & Phillippo, D. M., 14 Aug 2024, ISPOR Value and Outcomes Spotlight, 10, 4, p. 21-22 2 p.

    Research output: Contribution to specialist publicationFeatured article (Specialist Publication)

    Open Access

Cite this